1620 Investment Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$116K	Sell	924 -3	-0.3%	-$377	0.08%	211
2025 Q1	$103K	Sell	927 -6	-0.6%	-$664	0.08%	210
2024 Q4	$127K	Buy	933 +66	+8%	+$9.01K	0.1%	190
2024 Q3	$99.9K	Buy	867 +10	+1%	+$1.15K	0.07%	225
2024 Q2	$118K	Buy	+857	New	+$118K	0.09%	199